superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2021-03-31
- Valid until
- 2021-06-30
- Published
- 2021-05-06
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 714,200,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Regeneron Pharmaceuticals quarterly research and development: 742,900,000 United States dollar", as of 2021-03-31 (until 2021-06-30). Claim clm_4272E4D045DC, https://asof.is/claim/clm_4272E4D045DC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000180422021000017/0001804220-21-000017-index.htm.
APA
AsOf. (2021). Regeneron Pharmaceuticals quarterly research and development: 742,900,000 United States dollar (as of 2021-03-31 (until 2021-06-30)) [Record clm_4272E4D045DC]. Retrieved November 9, 2026, from https://asof.is/claim/clm_4272E4D045DC (source: https://www.sec.gov/Archives/edgar/data/872589/000180422021000017/0001804220-21-000017-index.htm)
BibTeX
@misc{asof_clm_4272E4D045DC,
author = {AsOf},
title = {Regeneron Pharmaceuticals quarterly research and development: 742,900,000 United States dollar},
year = {2021},
howpublished = {\url{https://asof.is/claim/clm_4272E4D045DC}},
note = {Claim clm\_4272E4D045DC, as of 2021-03-31 (until 2021-06-30); source: https://www.sec.gov/Archives/edgar/data/872589/000180422021000017/0001804220-21-000017-index.htm},
urldate = {2026-11-09}
}Supersedes
On the record
/claim/clm_4272E4D045DC.md/v1/claims/clm_4272E4D045DCsubmit a correction